Personalis, Inc. Common Stock

PSNL XNAS • SERVICES-MEDICAL LABORATORIES

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.2B

Short interest (May 15)

13.1%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.45%

↓ 1.0%

Available Shares

↓ 11.9%

Price Chart

Company Overview

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Company Info

Exchange: NASDAQ

Industry: SERVICES-MEDICAL LABORATORIES

CIK: 0001527753

Asset Type: CS

Market Data

Market Cap: $1,166,593,031

Employees: 260

Status: Active

Short Interest

Current Borrow Fee 0.45%

Range: 0.44% - 0.51%

Available Shares 1M

Range: 950K - 1M

Recent Changes

Fee Change: ↓ 0.3%

Available Change: ↑ 2.6%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime